Peptide Cycle Timelines
Week-by-week community-reported observations for 15 peptide protocols.
BPC-157
The most researched healing peptide. Angiogenesis, tissue repair, and gut health — backed by 50,000+ community reports.
TB-500
Thymosin Beta-4 fragment. Heals everywhere at once — shoulder, hip, knee simultaneously. Systemic flexibility and tissue repair.
CJC-1295 + Ipamorelin
The gold standard GH stack. Dual GHRH+GHRP synergy produces 5x more GH than either alone. Sleep, body composition, anti-aging, recovery.
Sermorelin
GHRH analog. Stimulates your pituitary's own GH production. Gentler, longer arc — the sustainable anti-aging protocol.
Semaglutide
GLP-1 receptor agonist. Silences food noise, resets the metabolic baseline, 14-16% average body weight loss at 52 weeks.
Tirzepatide
Dual GIP + GLP-1 agonist. SURMOUNT-1 trial: 22.5% average body weight loss at 72 weeks. Over half of max-dose patients lost 20%+.
MK-677
Oral GH secretagogue. No injections. Elevates GH and IGF-1 for muscle growth, fat loss, deep sleep, and skin improvements from a single nightly capsule.
PT-141
The only peptide that works on the brain, not blood flow. Activates hypothalamus receptors to produce genuine desire and arousal.
Epithalon
Tetrapeptide derived from pineal gland research. Targets telomere length, circadian biology, and cellular aging. Just 10 nightly injections per cycle.
GHK-Cu
Copper peptide that directly stimulates collagen, skin density, and hair follicle activation. Results compound over 8-12 weeks — then persist for months after stopping.
AOD-9604
GH fragment responsible for fat metabolism only — no anabolic or insulin effects. Targets stubborn visceral fat through lipolysis. No appetite suppression. No muscle effects.
Tesamorelin
GHRH analog FDA-approved for visceral fat reduction. Clinical data to 52 weeks. Targets deep abdominal fat specifically while optimizing GH. The most evidence-backed fat-targeting peptide.
IGF-1 LR3
Most potent anabolic peptide available. Drives nutrient partitioning to muscle preferentially. Short cycles only — receptor desensitization risk at 6+ weeks.
Thymosin Alpha-1
Immunomodulatory peptide that upregulates T-cell production. Strong community data for viral illness recovery, long COVID, and recurrent infections.
MOTS-c
Mitochondria-derived peptide activating AMPK for metabolic health, endurance, and insulin sensitivity. Only 4 weekly injections per cycle — 4 months off while adaptations compound.